1. Home
  2. Stock quotes
  3. Vertex Pharmaceuticals Incorporated
  4. Financial Ratios
  5. Cash Conversion Cycle
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 450.97 0.13%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Vertex Pharmaceuticals Incorporated Cash Conversion Cycle 2011-2024 | VRTX

Annual Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
132 106 106 95.6 109 69 107 71.8 14.9 -185 -72.8 -58.1 219

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
219 -185 54.9

Quarterly Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
204 188 168 - 136 124 120 - 68.3 55.7 113 - 124 122 120 106 114 115 103 80.3 116 115 100 52.9 58.6 61.4 81.8 80.5 91.8 95.7 83.2 39.9 44.3 42.5 43 38 51.8 97.6 83.5 48 38.7 50.1 62.2 22.2 35.2 25.1 31.8 39.1 38.9 31.2 33.9 29.7 25.4 146 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
204 22.2 80.3